{"status": "Ok", "redirect_url": "https://www.prnewswire.com//news-releases/investor-deadline-immunitybio-inc-ibrx-investors-with-substantial-losses-have-opportunity-to-lead-securities-class-action-lawsuit-302766194.html", "message": "News view counter 713058 successfully enlarged"}